Ivim Health review

Ivim Health: the price on the page is not the price on the card

Ivim advertises compounded semaglutide from $75 a month and compounded tirzepatide from $133. Both numbers are real, both are printed on public pages before any form, and both are medication only. Directly under every price panel on the site sits the line "+ $74.99 /mo Program fee" — a separate, required membership charge. Ivim's own membership page splits it out with no ambiguity at all: "Membership: $75 / mo" on one side, "Medication: Starting At $75 / mo" on the other. Two charges, near enough the same size. So the cheapest honest all-in figure here is about $150 a month, and that is the floor, not the rate.

That matters more than usual on this site because the cheap number is the one that travels. It is what shows up in an ad, in a friend's text, in a search result. If you budget from $75 and get billed $150, you have not been lied to — you have been shown one of two numbers.

And you cannot pay it month to month

The $75 and $133 rates buy a prepaid program, not a subscription you can leave. Ivim's microdosing page publishes the whole ladder, which is more than most sellers on this list do — and reading it across, rather than down, is the useful exercise:

The shape of that table is the whole commercial argument. Trying tirzepatide for two months costs $200 a month; committing to six drops it to $133. The difference between testing the water and signing up for half a year is fifty percent on the monthly rate — before the membership. Ivim's own program FAQ says most patients start on what it calls the Jumpstart option, a four-month commitment.

Two of Ivim's own surfaces disagree about where pricing starts

This is the finding that took the longest to reach and is the one worth carrying into a phone call. The marketing pages start compounded GLP-1s at $75 a month. The intake application — a separate app served from Ivim's own portal — carries this line in its own code: "Compounded GLP-1 Options: Starting at $249 / month". The same file also states "Medical programs require an Ivim membership at $74.99/month", which is how we know the $75 on the membership page and the $74.99 on the pricing panels are one fee and not two.

The likeliest explanation is that $75 buys a microdose on a long prepaid term and $249 is where standard dosing begins. That would be a perfectly reasonable business — but Ivim never says it. The ladder in the table above sits on the microdosing page. For standard treatment there is no dose ladder anywhere, no maintenance rate, and no ceiling. This is the same gap our cost cheat sheet is built around: the number you titrate up to is the number nobody publishes.

One point of honesty about how we know this. We did not sit through the intake and watch $249 appear on a screen — we read it out of the code the intake app ships to your browser. We also stopped short of creating an account or entering any health information, so what happens on the screens past the first one is not something we can tell you.

The off-ramp is where this gets genuinely hard

Ivim gives two different answers to "can I stop?", on two of its own documents. The GLP-1 ID page's FAQ says programs run for the length you choose and that "cancellation is not available once your program has started." Section 16 of the Terms and Conditions — the document you actually agree to, and therefore the one that governs — says something else: you can cancel, Ivim will refund medication that has not shipped, and it will keep "an administrative/restocking fee of $100 for each undeveloped three-month portion of your plan or $50 for each undeveloped two-month portion." Its own worked example is that ending a six-month plan after three months' shipments triggers one $100 fee.

Around that sit three more clauses that a stretched budget should know about, and they are worth reading next to our guide on maintenance and the off-ramp. The Returns Policy says "All prescribed medications are non-refundable, regardless of usage, program duration, or cancellation of membership." Section 29 says your Program Period runs in calendar months from the date of purchase, that you get a fourteen-day grace period after it ends, and that medication you did not request in time lapses at expiration with no credit and no extension. And refills require an active membership in good standing — so if the membership payment fails, the medication stops.

There is one fee waiver, and it is the one this site's readers are most likely to need: the restocking fee is dropped entirely if a provider determines you are medically ineligible to continue, "for instance, due to pregnancy or other documented contraindications." That clause is, as far as we could find, the only place on the entire Ivim site where pregnancy is mentioned at all.

What Ivim does better than most of this list

It would be easy to read the last three sections as a dismissal, and it is not one. Ivim's menu is one of the broadest here: compounded semaglutide and tirzepatide sit alongside brand-name Wegovy, Zepbound, Ozempic, Mounjaro and Saxenda, plus compounded liraglutide and two oral GLP-1s. Its own FAQ confirms it in plain words — "You still have full access to Zepbound and Wegovy if you choose through our traditional GLP-1 program." And the brand pricing is published rather than gated: the Wegovy Pill page states "Oral $149/month" and "Injectable $199/month", and in the same breath reminds you that the membership is billed separately. If what you actually want is FDA-approved medication rather than compounded, that page is the most useful thing on the site, and the comparison to think through is in the Wegovy pill against the shot.

It also does not hide behind a shell. The Returns Policy names Ivim Services LLC and Ivim Professional Corporation. The company says it was founded in 2021 by Dr. Taylor Kantor with his brother Anthony and Anthony's wife Kelly, it publishes a providers page, and it points at two peer-reviewed retrospective studies of its own patients in Obesity Pillars rather than asking you to take the outcome claims on trust. Its homepage claims 470,000-plus patients served and roughly a hundred board-certified providers. Retrospective observational studies are not randomized trials and Ivim's own footnotes say so — but publishing them at all is more than almost anyone else on this roster does.

You will need to book a visit, and you cannot check your state first

Both of Ivim's published patient journeys put a live clinician between you and the prescription. The GLP-1 ID journey reads "Video or chat visit with an Ivim provider to review history, goals, and create your treatment plan"; the microdosing journey says simply "Video Consultation." That is a real and deliberate difference from the questionnaire-only providers on this site, and it cuts both ways — you get a scheduled conversation with someone who can actually answer a question, and you have to find twenty minutes in a week that does not have twenty spare. The homepage advertises same-day provider visits, so at least the wait should be short. If a scheduled call is the dealbreaker, providers with no video visit is the list to read instead.

The coverage question has no answer at all. We read the homepage, both program pages, the membership page, the Wegovy Pill page, the Terms and the Returns Policy and found no state list, no exclusion list and no coverage checker anywhere. You find out during intake — which is after you have handed over your health history, and immediately before the screen that asks for the program fee.

The FDA warning letter, and what it actually says

Ivim carries FDA warning letter #721816, dated 20 February 2026, addressed to Ivim Services LLC dba Ivim at 4200 Regent Street, Suite 200, Columbus, Ohio. It names ivimhealth.com and the support email on the site, so there is no name-collision doubt: this is unambiguously this company. It stays listed here with the letter disclosed, because a mother searching for it deserves to find it discussed rather than quietly omitted.

The allegation is narrow and worth understanding rather than fearing. The FDA reviewed the site in December 2025 and objected that "the compounded semaglutide and tirzepatide products displayed on your website identify 'Ivim' on the pictured label, suggesting Ivim is the compounder of those drugs when in fact it is not." That is a misbranding charge under sections 502(a) and 502(bb) about who made the medicine, not a finding that anyone was harmed by it. It is also uncomfortably well aimed, because the gap it points at is still open: Ivim names no compounding pharmacy anywhere on its public site, so you cannot check who fills your prescription. That is the question to ask before you pay a program fee, and it is worth asking of any seller — the reasoning is in whether compounded semaglutide bought online is safe.

The bottom line

Ivim is a high-touch, prepaid, brand-and-compounded program wearing a budget price tag. If you want a clinician on a call rather than a form, if you are buying Wegovy or Zepbound rather than a compounded vial, and if you can commit to four or six months with a clear head about the $74.99 membership riding on top, it is a serious option and the published term ladder makes it costable in a way most of this list is not. If you are shopping the $75 headline, or you need to be able to stop in month two, or you need to know today whether it works in your state, this is not the one. Ask for three things in writing before you pay: what a maintenance dose costs, which pharmacy compounds it, and exactly what leaving in month three would cost you. Providers that answer all three up front are on our best GLP-1 providers for working moms board.